Aster DM Healthcare (NSE:ASTERDM, BOM:540975) has completed the acquisition of a 5% stake in Quality Care India Ltd (QCIL) from BCP Asia II TopCo IV and Centella Mauritius Holdings, according to a Wednesday filing.
The stake was purchased through a share swap valued at 8.49 billion Indian rupees, the filing said. Aster acquired around 19 million equity shares of QCIL and in return, issued around 18.6 million equity shares of Aster DM Healthcare to BCP and Centella, it added.
The move is part of the previously announced plan to merge QCIL with Aster, which was disclosed in November 2024, the filing said. The merged entity, to be called Aster DM Quality Care, will be jointly controlled by Aster promoters and BCP. The merger is expected to close later this year, subject to final listing and regulatory approvals, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.